Revvity (NYSE:RVTY) Receives New Coverage from Analysts at Jefferies Financial Group

Jefferies Financial Group began coverage on shares of Revvity (NYSE:RVTYFree Report) in a research note published on Monday, StockNewsAPI reports. The brokerage issued a hold rating and a $115.00 price target on the stock.

Other research analysts have also recently issued reports about the company. Robert W. Baird upped their price objective on Revvity from $126.00 to $127.00 and gave the stock an outperform rating in a research report on Tuesday, April 30th. TD Cowen increased their price target on Revvity from $123.00 to $130.00 and gave the company a buy rating in a research report on Tuesday, April 30th. Seven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, Revvity currently has an average rating of Moderate Buy and a consensus price target of $117.92.

Read Our Latest Stock Analysis on RVTY

Revvity Stock Down 0.4 %

RVTY stock opened at $108.80 on Monday. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.23 and a quick ratio of 1.92. The stock has a market capitalization of $13.42 billion, a P/E ratio of 89.92, a P/E/G ratio of 2.84 and a beta of 1.08. The business has a 50-day moving average of $105.48 and a 200-day moving average of $103.95. Revvity has a fifty-two week low of $79.50 and a fifty-two week high of $131.96.

Revvity (NYSE:RVTYGet Free Report) last posted its quarterly earnings data on Monday, April 29th. The company reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.04. The company had revenue of $649.90 million during the quarter, compared to analysts’ expectations of $646.83 million. Revvity had a return on equity of 7.37% and a net margin of 5.49%. Revvity’s revenue for the quarter was down 3.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.01 earnings per share. On average, sell-side analysts anticipate that Revvity will post 4.66 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 9th. Stockholders of record on Friday, July 19th will be given a $0.07 dividend. The ex-dividend date is Friday, July 19th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.26%. Revvity’s payout ratio is 23.14%.

Institutional Trading of Revvity

A number of hedge funds have recently made changes to their positions in RVTY. Parkside Financial Bank & Trust acquired a new stake in shares of Revvity in the fourth quarter valued at approximately $25,000. Gladius Capital Management LP increased its stake in shares of Revvity by 84.1% during the third quarter. Gladius Capital Management LP now owns 232 shares of the company’s stock worth $26,000 after purchasing an additional 106 shares during the period. CENTRAL TRUST Co bought a new position in shares of Revvity during the fourth quarter worth approximately $27,000. Benjamin F. Edwards & Company Inc. bought a new position in shares of Revvity during the fourth quarter worth approximately $27,000. Finally, ORG Partners LLC bought a new position in shares of Revvity during the fourth quarter worth approximately $32,000. 86.65% of the stock is owned by institutional investors and hedge funds.

Revvity Company Profile

(Get Free Report)

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Further Reading

Analyst Recommendations for Revvity (NYSE:RVTY)

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with's FREE daily email newsletter.